WILSON KAREN J
SEC insider (Form 3/4/5 filer). CIK 0001267490. Director at Elicio Therapeutics, Inc. (ELTX) and 3 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.
Companies WILSON KAREN J has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Director
- Serina Therapeutics, Inc. (SER): Director
- Connect Biopharma Holdings Ltd (CNTB): Director
- LAVA Therapeutics NV (LVTX): Director
WILSON KAREN J
CIK: 0001267490
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.8K shares- - Jun 17, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Jun 12, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect5K shares at avg. $1.77$9K - Jun 11, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect5.1K shares at avg. $1.75$9K - May 22, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect10K shares at avg. $1.93$19K - May 21, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect10K shares at avg. $1.77$18K - Nov 13, 2025LVTX
LAVA Therapeutics NV
DispositionDirect10K shares- - Nov 7, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.9K shares- - Feb 13, 2025LVTX
LAVA Therapeutics NV
AwardDirectCommon Shares (Right to Buy)
33.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,750 | - | - | Direct |
| Jun 17, 2026 |  SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 15,250 | - | - | Direct |
| Jun 12, 2026 | SER Serina Therapeutics, Inc. | Purchase | 5,000 | $1.77 | $8,850 | Direct |
| Jun 11, 2026 | SER Serina Therapeutics, Inc. | Purchase | 5,100 | $1.75 | $8,900 | Direct |
| May 22, 2026 | SER Serina Therapeutics, Inc. | Purchase | 10,000 | $1.93 | $19,300 | Direct |
| May 21, 2026 | SER Serina Therapeutics, Inc. | Purchase | 10,000 | $1.77 | $17,700 | Direct |
| Nov 13, 2025 |  LVTX LAVA Therapeutics NV | Disposition | 10,000 | - | - | Direct |
| Nov 7, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,900 | - | - | Direct |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | Award Common Shares (Right to Buy) | 33,390 | - | - | Direct |
1-10 of 12 transactions